US EditionBI Asset Management Fondsmaeglerselskab A S Decreases Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Q3 EPS Estimate for Quest Diagnostics Lifted by Analyst
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – William Blair boosted their Q3 2025 earnings per share estimates for Quest Diagnostics in a report issued on Tuesday, April 22nd. William Blair analyst A. Brackmann now expects that the medical research company will post earnings of $2.51 per share for the quarter, up from their prior […]
BI Asset Management Fondsmaeglerselskab A S Decreases Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
BI Asset Management Fondsmaeglerselskab A S lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,359 shares of the medical research company’s stock after selling 2,712 shares […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
